The online version of this article (doi:10.1186/1475-2875-11-279) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
Molecular tools are very sensitive and specific and could be an alternative for the diagnosis of malaria. The complexity and need for expensive equipment may hamper implementation and, therefore, simplifications to current protocols are warranted.
A PCR detecting the different Plasmodium species and differentiating between Plasmodium falciparum and Plasmodium vivax was developed and combined with a nucleic acid lateral flow immuno-assay (PCR-NALFIA) for amplicon detection. The assay was thoroughly evaluated for the analytical sensitivity and specificity in the laboratory, the robustness and reproducibility in a ring trial and accuracy and predictive value in a field trial.
The analytical sensitivity and specificity were 0.978 (95% CI: 0.932–0.994) and 0.980 (95% CI: 0.924-0.997), respectively, and were slightly less sensitive for the detection of P. vivax than for P. falciparum. The reproducibility tested in three laboratories was very good (k = 0.83). This evaluation showed that the PCR machine used could influence the results. Accuracy was evaluated in Thailand and compared to expert microscopy and rapid diagnostic tests (RDTs). The overall and P. falciparum-specific sensitivity and specificity was good ranging from 0.86-1 and 0.95-0.98 respectively, compared to microscopy. Plasmodium vivax detection was better than the sensitivity of RDT, but slightly less than microscopy performed in this study.
PCR-NALFIA is a sensitive, specific and robust assay able to identify Plasmodium species with good accuracy. Extensive testing including a ring trial can identify possible bottlenecks before implementation and is therefore essential to perform in additon to other evaluations.
Authors’ original file for figure 112936_2012_2192_MOESM1_ESM.png
World Health Organization: Guidelines for the treatment of malaria. 2010, WHO, Geneva, Second
Ansah EK, Narh-Bana S, Epokor M, Akanpigbiam S, Quartey AA, Gyapong J, Whitty CJ: Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana. BMJ. 2010, 340: c930-10.1136/bmj.c930. PubMedCentralCrossRefPubMed
Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, Boaz L, Lilley K, Krause D, Vallely A, Johnson ML, Gatton ML, Shanks GD, Cheng Q: A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar J. 2010, 9: 254-10.1186/1475-2875-9-254. PubMedCentralCrossRefPubMed
Meena M, Joshi D, Joshi R, Sridhar S, Waghdhare S, Gangane N, Kalantri SP: Accuracy of a multispecies rapid diagnostic test kit for detection of malarial parasite at the point of care in a low endemicity region. Trans R Soc Trop Med Hyg. 2009, 103: 1237-1244. 10.1016/j.trstmh.2009.04.011. CrossRefPubMed
Noguera P, Posthuma-Trumpie GA, van Tuil M, van der Wal FJ, de Boer A, Moers AP, van Amerongen A: Carbon nanoparticles in lateral flow methods to detect genes encoding virulence factors of Shiga toxin-producing Escherichia coli. Anal Bioanal Chem. 2011, 399: 831-838. 10.1007/s00216-010-4334-z. PubMedCentralCrossRefPubMed
Sahaa AJ, Hoover DR: “Sensitivity” and “specificity” reconsidered: the meaning of these terms in analytical and diagnostic settings. Ann Intern Med. 1997, 126: 91-94. CrossRef
Weinstein NA S, Obuchowski M, Lieber L: Clinical evaluation of diagnostic tests. Am J Roentgenology. 2005, 184: 14-19. CrossRef
World Organization of Animal Health: Principles and methods of validation of diagnostic assays for infectious diseases. Chapter 1.1.4/5. Terrestrial Manual. 2010, Office International des Epizooties, Paris, p1-p18.
SMRU-Shoklo Malaria Research Unit. 2012, http://www.shoklo-unit.com
World Health Organization: Basic malaria microscopy, Part I Learner's guide. 2010, World Health Organization, Geneva, 2
Fleiss JL, Levin B, Paik MC: Statistical Methods for Rates and Proportions. 2003, Wiley press, New York, 3 CrossRef
Altman DG: Practical Statistics for Medical Reseatch. 1991, Chapman & Hall, London, 611-
Sirichaisinthop J, Buates S, Watanabe R, Han ET, Suktawonjaroenpon W, Krasaesub S, Takeo S, Tsuboi T, Sattabongkot J: Evaluation of loop-mediated isothermal amplification (LAMP) for malaria diagnosis in a field setting. Am J Trop Med Hyg. 2011, 85: 594-596. 10.4269/ajtmh.2011.10-0676. PubMedCentralCrossRefPubMed
Schneider P, Wolters L, Schoone G, Schallig H, Sillekens P, Hermsen R, Sauerwein R: Real-time nucleic acid sequence-based amplification is more convenient than real-time PCR for quantification of Plasmodium falciparum. J Clin Microbiol. 2005, 43: 402-405. 10.1128/JCM.43.1.402-405.2005. PubMedCentralCrossRefPubMed
malERA consultative group on diagnoses and diagnostics: A research agenda for malaria eradiaction: diagnoses and diagnostics. PLoS Med. 2011, 8: 1000396- CrossRef
Mens P, Spieker N, Omar S, Heijnen M, Schallig H, Kager PA: Is molecular biology the best alternative for diagnosis of malaria to microscopy? A comparison between microscopy, antigen detection and molecular tests in rural Kenya and urban Tanzania. Trop Med Int Health. 2007, 12: 238-244. PubMed
- Development, validation and evaluation of a rapid PCR-nucleic acid lateral flow immuno-assay for the detection of Plasmodium and the differentiation between Plasmodium falciparum and Plasmodium vivax
Petra F Mens
Laura M de Bes
Jathee R s Sak
Chantal van Overmeir
Jaco J Verweij
Rachel L Hallett
Henk DFH Schallig
Aart van Amerongen
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II